scholarly article | Q13442814 |
P50 | author | Joan Puig-barberà | Q42649355 |
Ainara Mira-Iglesias | Q56862158 | ||
F X López-Labrador | Q71257032 | ||
Miguel Tortajada-Girbés | Q114340763 | ||
Germán Schwarz-Chavarri | Q117281766 | ||
Mario Carballido-Fernández | Q117281772 | ||
Víctor Baselga-Moreno | Q117281773 | ||
Juan Mollar-Maseres | Q117281776 | ||
Javier Diez-Domingo | Q38641991 | ||
P2093 | author name string | On Behalf Of The Valencia Hospital Network For The Study Of Influenza And Respiratory Viruses Disease | |
P2860 | cites work | Repeated annual influenza vaccination and vaccine effectiveness: review of evidence | Q39340731 |
Repeated Vaccination Does Not Appear to Impact Upon Influenza Vaccine Effectiveness Against Hospitalization With Confirmed Influenza | Q40280348 | ||
Effectiveness of influenza vaccination programme in preventing hospital admissions, Valencia, 2014/15 early results. | Q41289359 | ||
MF59-adjuvanted and virosomal influenza vaccines for preventing influenza hospitalization in older people: comparative effectiveness using the Valencia health care information system. | Q45109784 | ||
Low 2016/17 season vaccine effectiveness against hospitalised influenza A(H3N2) among elderly: awareness warranted for 2017/18 season | Q47135577 | ||
End-of-season influenza vaccine effectiveness in adults and children, United Kingdom, 2016/17. | Q47154049 | ||
Low interim influenza vaccine effectiveness, Australia, 1 May to 24 September 2017. | Q47159696 | ||
Low influenza vaccine effectiveness and the effect of previous vaccination in preventing admission with A(H1N1)pdm09 or B/Victoria-Lineage in patients 60 years old or older during the 2015/2016 influenza season. | Q47413448 | ||
Evidence for Viral Interference and Cross-reactive Protective Immunity Between Influenza B Virus Lineages. | Q47555103 | ||
Impact of seasonal influenza vaccination in the presence of vaccine interference | Q47564122 | ||
Early season co-circulation of influenza A(H3N2) and B(Yamagata): interim estimates of 2017/18 vaccine effectiveness, Canada, January 2018. | Q49204982 | ||
Repeated influenza vaccination for preventing severe and fatal influenza infection in older adults: a multicentre case-control study. | Q49400944 | ||
Interim 2017/18 influenza seasonal vaccine effectiveness: combined results from five European studies. | Q54261205 | ||
Typing (A/B) and subtyping (H1/H3/H5) of influenza A viruses by multiplex real-time RT-PCR assays. | Q54526160 | ||
Dominant influenza A(H3N2) and B/Yamagata virus circulation in EU/EEA, 2016/17 and 2017/18 seasons, respectively. | Q55224055 | ||
Influenza vaccine effectiveness in preventing hospitalisation of individuals 60 years of age and over with laboratory-confirmed influenza, Valencia Region, Spain, influenza season 2016/17. | Q55339340 | ||
Recommended composition of influenza virus vaccines for use in the 2017–2018 northern hemisphere influenza season | Q56763785 | ||
Rapid multiplex reverse transcription-PCR typing of influenza A and B virus, and subtyping of influenza A virus into H1, 2, 3, 5, 7, 9, N1 (human), N1 (animal), N2, and N7, including typing of novel swine origin influenza A (H1N1) virus, during the 2 | Q56977592 | ||
Vaccines against influenza WHO position paper – November 2012 | Q85607288 | ||
Interim effectiveness of trivalent influenza vaccine in a season dominated by lineage mismatched influenza B, northern Spain, 2017/18 | Q87852509 | ||
Assessing Residual Bias in Estimating Influenza Vaccine Effectiveness: Comparison of High-dose Versus Standard-dose Vaccines | Q93033985 | ||
Evolution and ecology of influenza A viruses | Q24634698 | ||
New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0 | Q27860476 | ||
Pandemic versus epidemic influenza mortality: a pattern of changing age distribution | Q28275622 | ||
Serial Vaccination and the Antigenic Distance Hypothesis: Effects on Influenza Vaccine Effectiveness During A(H3N2) Epidemics in Canada, 2010-2011 to 2014-2015. | Q30151372 | ||
Impact of influenza vaccination on seasonal mortality in the US elderly population. | Q30350187 | ||
Effectiveness of seasonal 2008-2009, 2009-2010 and pandemic vaccines, to prevent influenza hospitalizations during the autumn 2009 influenza pandemic wave in Castellón, Spain. A test-negative, hospital-based, case-control study | Q30394200 | ||
Impact of repeated vaccination on vaccine effectiveness against influenza A(H3N2) and B during 8 seasons | Q34393525 | ||
Influenza vaccine effectiveness in preventing influenza A(H3N2)-related hospitalizations in adults targeted for vaccination by type of vaccine: a hospital-based test-negative study, 2011-2012 A(H3N2) predominant influenza season, Valencia, Spain | Q34505958 | ||
Potential of the test-negative design for measuring influenza vaccine effectiveness: a systematic review | Q34778408 | ||
Influenza B virus-specific CD8+ T-lymphocytes strongly cross-react with viruses of the opposing influenza B lineage | Q36376605 | ||
The active comparator, new user study design in pharmacoepidemiology: historical foundations and contemporary application | Q36653410 | ||
Influenza B vaccine lineage selection--an optimized trivalent vaccine | Q36690569 | ||
Indicators of socioeconomic position (part 2). | Q36933672 | ||
The test-negative design for estimating influenza vaccine effectiveness | Q38427246 | ||
Repeated seasonal influenza vaccination among elderly in Europe: Effects on laboratory confirmed hospitalised influenza. | Q38678530 | ||
Influenza Vaccine Effectiveness in Preventing Influenza Illness Among Children During School-based Outbreaks in the 2014-2015 Season in Beijing, China | Q39142665 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 31 | |
P921 | main subject | influenza vaccine | Q383260 |
periodic health examination | Q1762591 | ||
P577 | publication date | 2019-08-01 | |
P1433 | published in | Eurosurveillance | Q14565070 |
P1476 | title | Influenza vaccine effectiveness against laboratory-confirmed influenza in hospitalised adults aged 60 years or older, Valencia Region, Spain, 2017/18 influenza season | |
P478 | volume | 24 |
Q89543170 | Vaccine effectiveness against influenza A(H3N2) and B among laboratory-confirmed, hospitalised older adults, Europe, 2017-18: A season of B lineage mismatched to the trivalent vaccine | cites work | P2860 |
Search more.